Gene G. Kinney Ph.D.
Net Worth

Last updated:

What is Gene G. Kinney Ph.D. net worth?

The estimated net worth of Dr. Gene G. Kinney Ph.D. is at least $16,885,945 as of 17 May 2023. He owns shares worth $108,996 as insider, has earned $6,864,629 from insider trading and has received compensation worth at least $9,912,320 in Prothena Corporation plc.

What is the salary of Gene G. Kinney Ph.D.?

Dr. Gene G. Kinney Ph.D. salary is $901,120 per year as Pres, Chief Executive Officer & Director in Prothena Corporation plc.

How old is Gene G. Kinney Ph.D.?

Dr. Gene G. Kinney Ph.D. is 56 years old, born in 1969.

What stocks does Gene G. Kinney Ph.D. currently own?

As insider, Dr. Gene G. Kinney Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Prothena Corporation plc (PRTA) Pres, Chief Executive Officer & Director 12,793 $8.52 $108,996

What does Prothena Corporation plc do?

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a humanized monoclonal antibody, which is in Phase IIb clinical trial for the treatment of Parkinson's disease; PRX004 that completed Phase I clinical trial for the treatment of Transthyretin amyloidosis; and PRX005, which is in Phase I clinical trial for the treatment of Alzheimer's disease. Its discovery and preclinical programs include PRX012 for the treatment of Alzheimer's disease; and dual Aß-Tau vaccine for the treatment and prevention of Alzheimer's disease. Prothena Corporation plc has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target alpha-synuclein; and a collaboration agreement with Bristol-Myers Squibb to develop antibodies. The company was founded in 2012 and is based in Dublin, Ireland.

PRTA logo
PRTA
Prothena Corporation plc
$8.52

Gene G. Kinney Ph.D. insider trading

Prothena Corporation plc

Dr. Gene G. Kinney Ph.D. has made 29 insider trades between 2014-2023, according to the Form 4 filled with the SEC. Most recently he sold 14,934 units of PRTA stock worth $1,112,508 on 17 May 2023.

The largest trade he's ever made was exercising 45,000 units of PRTA stock on 17 May 2023. As of 17 May 2023 he still owns at least 12,793 units of PRTA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Ordinary Shares, par value $0.01 per share 14,934 $74.5 $1,112,508
Option
Ordinary Shares, par value $0.01 per share 45,000 $29.81 $1,341,450
Option
Stock Option (Right to Buy) 45,000 $29.81 $1,341,450
Sale
Ordinary Shares, par value $0.01 per share 10,202 $72.7 $741,726
Sale
Ordinary Shares, par value $0.01 per share 19,864 $73.6 $1,462,070
Sale
Ordinary Shares, par value $0.01 per share 2,333 $52.44 $122,343
Option
Stock Option (Right to Buy) 16,412 $6.41 $105,201
Sale
Ordinary Shares, par value $0.01 per share 5,852 $53.4 $312,479
Sale
Ordinary Shares, par value $0.01 per share 40 $56.19 $2,248
Sale
Ordinary Shares, par value $0.01 per share 243 $57.7 $14,022
Sale
Ordinary Shares, par value $0.01 per share 1,045 $48.09 $50,254
Sale
Ordinary Shares, par value $0.01 per share 128 $49.41 $6,324
Sale
Ordinary Shares, par value $0.01 per share 552 $51.3 $28,318
Sale
Ordinary Shares, par value $0.01 per share 4,748 $54.38 $258,177
Option
Ordinary Shares, par value $0.01 per share 16,412 $6.41 $105,201
Sale
Ordinary Shares, par value $0.01 per share 1,342 $55.32 $74,245
Sale
Ordinary Shares, par value $0.01 per share 129 $58.93 $7,602
Option
Stock Option (Right to Buy) 2,720 $6.41 $17,435
Sale
Ordinary Shares, par value $0.01 per share 2,720 $32.02 $87,089
Option
Ordinary Shares, par value $0.01 per share 2,720 $6.41 $17,435
Sale
Ordinary Shares, par value $0.01 per share 2,181 $32.03 $69,855
Option
Ordinary Shares, par value $0.01 per share 2,181 $6.41 $13,980
Option
Stock Option (Right to Buy) 2,181 $6.41 $13,980
Option
Stock Option (Right to Buy) 991 $6.41 $6,352
Option
Stock Option (Right to Buy) 13,650 $6.41 $87,497
Option
Ordinary Shares, par value $0.01 per share 20,284 $6.41 $130,020
Option
Stock Option (Right to Buy) 20,284 $6.41 $130,020
Sale
Ordinary Shares, par value $0.01 per share 20,284 $32.16 $652,293
Option
Ordinary Shares, par value $0.01 per share 13,650 $6.41 $87,497
Sale
Ordinary Shares, par value $0.01 per share 13,650 $32.16 $438,929
Option
Ordinary Shares, par value $0.01 per share 991 $6.41 $6,352
Sale
Ordinary Shares, par value $0.01 per share 991 $32.01 $31,724
Sale
Ordinary Shares, par value $0.01 per share 16,833 $32.77 $551,567
Option
Stock Option (Right to Buy) 20,954 $6.41 $134,315
Sale
Ordinary Shares, par value $0.01 per share 4,673 $33.06 $154,503
Option
Stock Option (Right to Buy) 21,506 $6.41 $137,853
Option
Ordinary Shares, par value $0.01 per share 21,506 $6.41 $137,853
Sale
Ordinary Shares, par value $0.01 per share 20,954 $32.18 $674,321
Option
Ordinary Shares, par value $0.01 per share 20,954 $6.41 $134,315
Option
Stock Option (Right to Buy) 376 $6.41 $2,410
Option
Ordinary Shares, par value $0.01 per share 376 $6.41 $2,410
Sale
Ordinary Shares, par value $0.01 per share 376 $32 $12,032
Option
Stock Option (Right to Buy) 10,000 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 10,000 N/A N/A
Option
Stock Option (right to buy) 2,800 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 2,800 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 2,800 N/A N/A
Option
Stock Option(right to buy) 25,163 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 25,163 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 25,163 N/A N/A
Option
Stock Option(right to buy) 3,796 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 3,796 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 3,796 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 8,548 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 8,548 N/A N/A
Option
Stock Option (right to buy) 8,548 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 5,834 N/A N/A
Option
Stock Option (right to buy) 5,834 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 5,834 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 14,785 N/A N/A
Option
Stock Option (right to buy) 14,785 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 14,785 N/A N/A
Sale
Ordinary Shares, par value $0.01 per share 30,000 N/A N/A
Option
Ordinary Shares, par value $0.01 per share 30,000 N/A N/A
Option
Stock Option (right to buy) 30,000 N/A N/A
Purchase
Ordinary Shares, par value $0.01 per share 2,500 N/A N/A

Prothena Corporation key executives

Prothena Corporation plc executives and other stock owners filed with the SEC: